Gene · 8473
Papers4,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GFAT1 promotes the progression of hepatocellular carcinoma via enhancing the O-GlcNAcylation of VEZF1. | Cell Death Dis | 2025 | 40858565 | PubTator, text mining | PubMed |
| An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALS. | Sci Adv | 2025 | 40845103 | PubTator, text mining | PubMed |
| Research and development prospects of TRIM65. | J Cancer Res Clin Oncol | 2025 | 40844633 | PubTator, text mining | PubMed |
| The Hsp40 co-chaperone DNAJC7 modifies polyglutamine but not polyglycine aggregation. | bioRxiv | 2025 | 40832276 | PubTator, text mining | PubMed |
| Integrating miRNA profiling and machine learning for improved prostate cancer diagnosis. | Sci Rep | 2025 | 40830224 | PubTator, text mining | PubMed |
| O-GlcNAc transferase plays dual antiviral roles by integrating innate immunity and lipid metabolism. | Nat Commun | 2025 | 40830102 | PubTator, text mining | PubMed |
| Participation of host cell proteins in inclusion bodies of non-segmented RNA virus infected cells: a molecular insight. | Virol J | 2025 | 40826091 | PubTator, text mining | PubMed |
| GALNT7 Stratifies dMMR/MSI Colorectal Cancer into Distinct Molecular Subsets Associated with Prognosis and PD-L1 Expression. | Cancer Res Commun | 2025 | 40824763 | PubTator, text mining | PubMed |
| Protein glycosylation modification as a novel forensic biomarker for discriminating monozygotic twins. | Forensic Sci Int | 2025 | 40819473 | PubTator, text mining | PubMed |
| CD31 regulates metabolic switch in Treg migration attenuates rheumatoid arthritis. | Clin Transl Med | 2025 | 40817604 | PubTator, text mining | PubMed |
| Prognostic and therapeutic implications related to glycosylation profiles of cancer-associated fibroblasts in colorectal cancer: insights from single-cell and bulk transcriptomics. | Funct Integr Genomics | 2025 | 40813526 | PubTator, text mining | PubMed |
| Transcriptomic Signatures in TP53 Positive and Negative Tumor Samples in NSCLC. | Curr Gene Ther | 2025 | 40798960 | PubTator, text mining | PubMed |
| Evidence for functional regulation of the KLHL3/WNK pathway by O-GlcNAcylation. | Glycobiology | 2025 | 40796245 | PubTator, text mining | PubMed |
| O-GlcNAc modulation of nuclear pore complexes orchestrates mRNA export efficiency. | Proc Natl Acad Sci U S A | 2025 | 40773237 | PubTator, text mining | PubMed |
| The HBP Pathway Inhibitor FR054 Enhances Temozolomide Sensitivity in Glioblastoma Cells by Promoting Ferroptosis and Inhibiting O-GlcNAcylation. | CNS Neurosci Ther | 2025 | 40772310 | PubTator, text mining | PubMed |
| [Expression of Concern] Alterations in left ventricular function during intermittent hypoxia: Possible involvement of O-GlcNAc protein and MAPK signaling. | Int J Mol Med | 2025 | 40747649 | PubTator, text mining | PubMed |
| Severe attenuation of circadian clock output in the heart following sustained augmentation of cardiomyocyte protein O-GlcNAcylation. | Front Cardiovasc Med | 2025 | 40747493 | PubTator, text mining | PubMed |
| Combinational Analysis of Metabolomic and O-GlcNAcylation Omics Reveals the HBP Metabolic Regulation of Chemoresistance via GFPT1/NR3C1 O-GlcNAcylation/GPX4 Axis. | Research (Wash D C) | 2025 | 40740652 | PubTator, text mining | PubMed |
| Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications. | J Hematol Oncol | 2025 | 40739259 | PubTator, text mining | PubMed |
| Endoplasmic reticulum-mitochondria coupling prompts ZBP1-mediated RPE cell PANoptosis in age-related macular degeneration. | Commun Biol | 2025 | 40731132 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8473/papers?page=12